Johnson & Johnson
Stock futures slip as investors await more bank earnings and inflation data: Live updates
Traders work on the floor of the New York Stock Exchange moments before the Closing Bell and the start of President Donald Trump’s news conference on tariffs on April 02, 2025 in New York City. Spencer Platt | Getty Images Stock futures ticked lower on Tuesday evening, as investors awaited earnings releases from several big […]
Read More
Earnings playbook: The reporting season kicks off with big banks and Netflix on deck
It’s that time again. The second-quarter earnings season kicks off this week with 37 companies that are members of the S & P 500 index set to report. Among the most notable companies outlining how they performed in the quarter ended June 30: big banks, led by JPMorgan Chase , the largest in the land, […]
Read More
This coming earnings season could decide if a stock market at record highs has more room to run
The upcoming earnings season will show investors whether the bull case for equities still holds. The second quarter reporting season comes at a pivotal point for the stock market, with the S & P 500 and Nasdaq Composite trading at all-time highs this week even after an onslaught of bad news regarding higher tariffs, a […]
Read More
Trump’s 200% tariff threat leaves pharma firms scrambling with scenario planning
Shelf of pharmaceutical products. D3sign | Moment | Getty Images The pharmaceutical industry is scrambling with scenario planning as U.S. President Donald Trump’s 200% tariff proposal threatens to drive up drug prices and rip out corporate profit margins. The president once again warned on Tuesday that long-awaited industry-wide tariffs would be announced “very soon” after […]
Read More
Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’
U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.” “They’re going to be tariffs […]
Read More
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care […]
Read More
Stock futures are flat after investors sell tech names to start the second half of 2025: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading on April 07, 2025 in New York City. Michael M. Santiago | Getty Images Stock futures were little changed on Tuesday evening, after investors began the second half with a reduced appetite for technology stocks. Futures tied to the Dow Jones […]
Read More
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan
The Johnson & Johnson logo displayed on a monitor. Sopa Images | Lightrocket | Getty Images Two Democratic lawmakers on Tuesday pressed five of the nation’s largest pharmaceutical companies about their low tax bills and whether they support extending massive tax cuts for the industry in the GOP reconciliation bill. Sen. Elizabeth Warren, D-Mass., and […]
Read More
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer
Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its […]
Read More
Trump to sign order to cut some U.S. drug prices to match lower ones abroad
President Donald Trump on Monday will revive a controversial policy that aims to slash drug costs by tying the amount the government pays for some medicines to lower prices abroad, White House officials said. Trump will sign an executive order including several different actions to renew that effort, known as the “most favored nation” policy. […]
Read More